Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Oncol.

Sec. Cancer Metabolism

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1604227

Regulation of Sphingolipid Metabolism in the Immune Microenvironment of Gastric Cancer: Current Insights and Future Directions

Provisionally accepted
Yunqi  HuaYunqi Hua1Gangling  ZhangGangling Zhang1Yubo  LiuYubo Liu2Xiaoling  TianXiaoling Tian2xinyi  Zhangxinyi Zhang1Ge  SongGe Song2Qinggang  TianQinggang Tian1*Fangrui  YinFangrui Yin3*
  • 1Baotou Cancer Hospital, Baotou, China
  • 2Baotou Medical College, Baotou, China
  • 3First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia, China

The final, formatted version of the article will be published soon.

In recent years, the role of sphingolipid metabolism in the tumor immune microenvironment has gradually gained attention, particularly in gastric cancer research. Sphingolipids are crucial components of cell membranes that regulate cell signaling and immune responses, making them important in tumor biology research.Despite numerous studies exploring the relationship between sphingolipid metabolism and gastric cancer, the specific regulatory mechanisms remain unclear. Further investigation is needed to understand their roles in the immune microenvironment.

Keywords: Sphingolipid metabolism, gastric cancer, immune microenvironment, Regulatory role, Mechanistic research

Received: 01 Apr 2025; Accepted: 14 Jul 2025.

Copyright: © 2025 Hua, Zhang, Liu, Tian, Zhang, Song, Tian and Yin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Qinggang Tian, Baotou Cancer Hospital, Baotou, China
Fangrui Yin, First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.